| Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma | Nature communications |  | | 2026 | 40 | 25 |
|
| Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma | JCI insight | | | 2025 | 9 | 38 |
|
| Targeting HIF-2α in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade | Cellular and molecular life sciences | | | 2025 | 197 | 166 |
|
| Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma | Journal for immunotherapy of cancer | | | 2025 | 10 | 35 |
|
| Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence | Nature biomedical engineering | | | 2025 | 36 | 29 |
|
| PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma | Cancer immunology research | | | 2024 | 312 | 379 |
|
| Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland) : Study of Incidence, Management and Outcomes | Cancers | | | 2024 | 100 | 572 |
|
| Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial | Nature cancer |  | | 2024 | 392 | 3 |
|
| PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma | | | | 2023 | 253 | 804 |
|
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | | 2023 | 335 | 292 |
|
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | | | 2021 | 345 | 172 |
|
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | | 2021 | 271 | 412 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 354 | 254 |
|
| An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | | | 2020 | 494 | 357 |
|
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | | | 2020 | 471 | 372 |
|
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | | | 2020 | 362 | 213 |
|
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | | 2019 | 864 | 932 |
|
| Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | | | 2019 | 380 | 257 |
|
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | | 2018 | 442 | 1 |
|
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | | | 2018 | 676 | 459 |
|
| Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing | PloS one | | | 2016 | 681 | 737 |
|
| Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | | | 2016 | 471 | 0 |
|
